Sarcopenia in urologic oncology: Identification and strategies to improve patient outcomes.

Sarcopenia in urologic oncology: Identification and strategies to improve patient outcomes. Urol Oncol. 2020 May 24;: Authors: Robertson HL, Michel C, Bartl L, Hamilton-Reeves JM Abstract Sarcopenia is the loss of muscle mass and function related to aging, undereating, disease conditions, or inactivity. Pre-existing sarcopenia diminishes the functional reserve of patients with cancer which increases their risk for frailty, cancer cachexia, and worse outcomes from treatments. The pathogenesis of sarcopenia is multi-factorial: opening opportunities for clinicians to work across disciplines to improve patient outcomes and quality of life. The purpose of this essay is to describe sarcopenia, discuss clinical screening and assessment for sarcopenia, and highlight potential interventions to manage sarcopenia in the urologic oncology population. PMID: 32456854 [PubMed - as supplied by publisher]
Source: Urologic Oncology - Category: Urology & Nephrology Authors: Tags: Urol Oncol Source Type: research